Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

ESSENTIALS: The role of statins in hemostasis and venous thromboembolism (VTE) prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin generation in patients with VTE. Endogenous thrombin potential and peak were decreased by 10% and 5% with rosuvastatin therapy. These...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thromb Haemost
Auteurs principaux: Orsi, Fernanda A., Biedermann, Joseph S., Kruip, Marieke J.H.A., van der Meer, Felix J., Rosendaal, Frits R., van Hylckama Vlieg, Astrid, Bos, Mettine H. A., Leebeek, Frank W. G., Cannegieter, Suzanne C., Lijfering, Willem M.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
CLINICAL HEMOSTASIS AND THROMBOSIS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850636/
https://ncbi.nlm.nih.gov/pubmed/30565854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14364
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires